Results 141 to 150 of about 3,004 (160)

Diagnosis of osteoporosis and assessment of fracture risk

Lancet, The, 2002
John A Kanis
exaly  

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

Lancet, The, 2015
Benjamin Z Leder, Hang Lee, Sherri-Ann M Burnett-Bowie   +2 more
exaly  

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Lancet, The, 2017
Cesar Libanati, Jacques P Brown, Klaus Engelke   +2 more
exaly  

A broader strategy for osteoporosis interventions

Nature Reviews Endocrinology, 2020
Ian Reid
exaly  

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial

Lancet, The, 2013
Hang Lee, Sherri-Ann M Burnett-Bowie, Benjamin Z Leder   +2 more
exaly  

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

Lancet, The, 2009
David M Reid, Kenneth G Saag, Jean-Yves Reginster   +2 more
exaly  

Osteoporosis

Lancet, The, 2019
Juliet Compston, Michael McClung, William D Leslie   +2 more
exaly  

Genetics of osteoporosis from genome-wide association studies: advances and challenges

Nature Reviews Genetics, 2012
J Brent Richards, Hou-Feng Zheng
exaly  

PROSTATE PATIENTS NOT ALWAYS CHECKED FOR OSTEOPOROSIS

Ca-A Cancer Journal for Clinicians, 2005
exaly  

A road map for understanding molecular and genetic determinants of osteoporosis

Nature Reviews Endocrinology, 2019
Tie-Lin Yang, Anqi Liu, Shan-Shan Dong
exaly